Publications by authors named "Gordon Mallarkey"

Claim this Profile
W
What we are doing to help researchers publish their papers in our journal.
Gordon Mallarkey, Matthew Thorne

J Int Med Res· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic management of hyperlipoproteinemia (a).
Constantine E Kosmas, Andreas Sourlas, Gordon Mallarkey, Delia Silverio, Domingo Y Ynoa

Drugs Context· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac myosin activators for heart failure therapy: focus on omecamtiv mecarbil.
Edgardo Kaplinsky, Gordon Mallarkey

Drugs Context· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European Society for Medical Oncology Copenhagen update: potential practice-changing findings.
Gordon Mallarkey, Axel Grothey

Ther Adv Med Oncol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteoporosis therapeutics: recent developments at ASBMR.
Gordon Mallarkey, David M Reid

Ther Adv Musculoskelet Dis· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Latest therapeutic advances in musculoskeletal disease from the ACR 2015 annual conference.
David M Reid, Gordon Mallarkey

Ther Adv Musculoskelet Dis· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting precision medicine toxicity: recent developments.
Gordon Mallarkey, Arduino A Mangoni

Ther Adv Drug Saf· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted therapies in medical oncology: successes, failures and next steps.
Gordon Mallarkey, R Charles Coombes

Ther Adv Med Oncol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathways and biomarkers in breast cancer: latest evidence.
Gordon Mallarkey, R Charles Coombes

Ther Adv Med Oncol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Latest drug safety alerts from the 27th International Conference on Pharmacoepidemiology and Therapeutic Risk Management.
Gordon Mallarkey, Arduino A Mangoni

Ther Adv Drug Saf· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Latest advances in the medical treatment of cancer: a 2011 snapshot.
Gordon Mallarkey, R Charles Coombes

Ther Adv Med Oncol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing breast cancer therapy by translational research: highlights of the Improving Care and Knowledge through Translational Research (IMPAKT) breast cancer conference.
Gordon Mallarkey, R Charles Coombes

Ther Adv Med Oncol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Looking at the causes of, and possible treatments for, psychiatric diseases: gene-environment interactions, circadian rhythms and neuronal dysfunction.
Gordon Mallarkey, Philip B Mitchell

Ther Adv Chronic Dis· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Latest advances in medical oncology: highlights from Milan ESMO 2010 annual congress.
Gordon Mallarkey, R Charles Coombes

Ther Adv Med Oncol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug safety advances from ICPE 2010.
Gordon Mallarkey, Arduino A Mangoni

Ther Adv Drug Saf· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Latest therapeutic advances from the ASCO 2010 Annual Meeting.
R Charles Coombes, Gordon Mallarkey

Ther Adv Med Oncol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacovigilance and pharmacogenetic discussions at WorldPharma 2010.
Gordon Mallarkey, Arduino A Mangoni

Ther Adv Drug Saf· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highlights of the 2nd European lung cancer conference.
Frances A Shepherd, Gordon Mallarkey

Ther Adv Med Oncol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liaison between public hospital staff and the pharmaceutical industry: guidance from the NSW Therapeutic Advisory Group.
Diana H Shipp, Gordon Mallarkey

Med J Aust· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An evaluation of eptacog alfa in nonhaemophiliac conditions.
Gordon Mallarkey, Tim Brighton, Amanda Thomson, Karen Kaye, Paul Seale

Drugs· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What are the therapeutic advances in gastroenterology? opinions from world experts.
Timothy Cragin Wang, Gordon Mallarkey

Therap Adv Gastroenterol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of adalimumab in Crohn's disease.
Gary R Lichtenstein, Remo Panaccione, Gordon Mallarkey

Therap Adv Gastroenterol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What are the Therapeutic Advances in Neurology? Opinions from World Experts.
Gordon Mallarkey

Ther Adv Neurol Disord· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of packaging of dose administration aids in regional aged care facilities in the Hunter area of New South Wales.
Annette Carruthers, Kialie Naughton, Gordon Mallarkey

Med J Aust· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Esomeprazole: a review of its use in the management of acid-related disorders.
Lesley J Scott, Christopher J Dunn, Gordon Mallarkey, Miriam Sharpe

Drugs· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis